Please log in to view this page
Username
Password
A5314 is a phase II randomized, double-blind, placebo-controlled 36-week trial that will examine the safety and efficacy of...
TB is a major cause of illness and death in women of reproductive age. Pregnant and postpartum women with latent TB are at...
The A5322 protocol is a long-term observational study, with a planned series of analyses of data to be collected from an...
We will address our hypothesis using a case-control study design. We plan to leverage the existing biorepository of...
This purpose of this study is to evaluate the pharmacokinetics (PK), safety, and tolerability of bedaquiline (BDQ) in...
